OPKO Health Stock Forecast, Price & News

OPKO Health (NASDAQ:OPK) Frequently Asked Questions

Is OPKO Health a buy right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for OPKO Health in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" OPKO Health stock.
View analyst ratings for OPKO Health or view top-rated stocks.

What stocks does MarketBeat like better than OPKO Health?

Wall Street analysts have given OPKO Health a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but OPKO Health wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is OPKO Health's next earnings date?

OPKO Health is scheduled to release its next quarterly earnings announcement on Thursday, November 4th 2021.
View our earnings forecast for OPKO Health.

How were OPKO Health's earnings last quarter?

OPKO Health, Inc. (NASDAQ:OPK) posted its earnings results on Thursday, July, 29th. The biotechnology company reported ($0.03) EPS for the quarter, missing the Zacks' consensus estimate of $0.02 by $0.05. The biotechnology company earned $442.40 million during the quarter, compared to analyst estimates of $457.57 million. OPKO Health had a net margin of 3.71% and a trailing twelve-month return on equity of 4.21%.
View OPKO Health's earnings history.

How has OPKO Health's stock been impacted by Coronavirus?

OPKO Health's stock was trading at $1.69 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, OPK shares have increased by 121.9% and is now trading at $3.75.
View which stocks have been most impacted by COVID-19.

What price target have analysts set for OPK?

2 equities research analysts have issued twelve-month price targets for OPKO Health's stock. Their forecasts range from $6.00 to $7.00. On average, they anticipate OPKO Health's stock price to reach $6.50 in the next twelve months. This suggests a possible upside of 73.3% from the stock's current price.
View analysts' price targets for OPKO Health or view top-rated stocks among Wall Street analysts.

Who are OPKO Health's key executives?

OPKO Health's management team includes the following people:

• Phillip Frost, Chairman & Chief Executive Officer
• Jon Roger Cohen, Director & Senior Vice President
• Adam E. Logal, CFO, Treasurer, Chief Accounting Officer & SVP
• Jane H. Hsaio, Vice Chairman & Chief Technical Officer
• Steven D. Rubin, Director & Executive Vice President-Administration

What is Philip Frost's approval rating as OPKO Health's CEO?

21 employees have rated OPKO Health CEO Philip Frost on Glassdoor.com. Philip Frost has an approval rating of 16% among OPKO Health's employees. This puts Philip Frost in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of OPKO Health's key competitors?

Some companies that are related to OPKO Health include Amgen (AMGN), Gilead Sciences (GILD), Regeneron Pharmaceuticals (REGN), Vertex Pharmaceuticals (VRTX), Biogen (BIIB), Seagen (SGEN), Alnylam Pharmaceuticals (ALNY), Novavax (NVAX), Repligen (RGEN), Exact Sciences (EXAS), Incyte (INCY), BioMarin Pharmaceutical (BMRN), Neurocrine Biosciences (NBIX), United Therapeutics (UTHR) and Exelixis (EXEL).
View all of OPK's competitors.

What other stocks do shareholders of OPKO Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other OPKO Health investors own include TherapeuticsMD (TXMD), Micron Technology (MU), NVIDIA (NVDA), bluebird bio (BLUE), Gilead Sciences (GILD), Pfizer (PFE), Inovio Pharmaceuticals (INO), Novavax (NVAX), Advanced Micro Devices (AMD) and AT&T (T).

What is OPKO Health's stock symbol?

OPKO Health trades on the NASDAQ under the ticker symbol "OPK."

Who are OPKO Health's major shareholders?

OPKO Health's stock is owned by a variety of institutional and retail investors. Top institutional investors include Vanguard Group Inc. (5.25%), BlackRock Inc. (5.20%), State Street Corp (3.05%), Geode Capital Management LLC (1.14%), Dimensional Fund Advisors LP (1.06%) and Northern Trust Corp (0.96%). Company insiders that own OPKO Health stock include Anthony J Japour, Jane Ph D Hsiao, Jon R Cohen, Phillip Md Et Al Frost, Richard C Pfenniger Jr, Robert J Shovlin and Steven D Rubin.
View institutional ownership trends for OPKO Health.

Which major investors are selling OPKO Health stock?

OPK stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., FMR LLC, Principal Financial Group Inc., Marshall Wace LLP, Marshall Wace LLP, Dimensional Fund Advisors LP, AQR Capital Management LLC, and Cubist Systematic Strategies LLC.
View insider buying and selling activity for OPKO Health or view top insider-selling stocks.

Which major investors are buying OPKO Health stock?

OPK stock was acquired by a variety of institutional investors in the last quarter, including State Street Corp, Renaissance Technologies LLC, Group One Trading L.P., Northern Trust Corp, Prudential Financial Inc., Connor Clark & Lunn Investment Management Ltd., Oracle Investment Management Inc., and Landscape Capital Management L.L.C.. Company insiders that have bought OPKO Health stock in the last two years include Anthony J Japour, Jane Ph D Hsiao, Jon R Cohen, Phillip Md Et Al Frost, Richard C Pfenniger Jr, and Steven D Rubin.
View insider buying and selling activity for OPKO Health or or view top insider-buying stocks.

How do I buy shares of OPKO Health?

Shares of OPK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is OPKO Health's stock price today?

One share of OPK stock can currently be purchased for approximately $3.75.

How much money does OPKO Health make?

OPKO Health has a market capitalization of $2.55 billion and generates $1.44 billion in revenue each year. The biotechnology company earns $30.59 million in net income (profit) each year or $0.05 on an earnings per share basis.

How many employees does OPKO Health have?

OPKO Health employs 5,269 workers across the globe.

What is OPKO Health's official website?

The official website for OPKO Health is www.opko.com.

Where are OPKO Health's headquarters?

OPKO Health is headquartered at 4400 BISCAYNE BLVD., MIAMI FL, 33137.

How can I contact OPKO Health?

OPKO Health's mailing address is 4400 BISCAYNE BLVD., MIAMI FL, 33137. The biotechnology company can be reached via phone at (305) 575-4100 or via email at [email protected].